Dr Chidi Nweneka is a distinguished Global Health and Management expert, who has had an illustrious career spanning over two decades, marked by exceptional contributions to management, leadership, and strategy in global health and infectious diseases.

He is a Global Health and Management Consultant and Principal Partner at Virtues Consulting LLC.

He is a member of Aspen Pharmacare Holdings Limited Group Executive Committee and is the Group Senior Executive responsible for Strategic Trade Development. Previously Stavros was CEO of Aspen’s Export Business. He was instrumental in introducing the first generic ARV’s on the African Continent developed by Aspen, which has gone on to save hundreds of thousands of lives in South Africa and on the African Continent.

Dr Nweneka has made significant contributions to critical initiatives like the Partnerships for African Vaccine Manufacturing (PAVM) Initiative, where he served as a member of the Market Design and Demand Intelligence Workgroup. As the PMO for the Technology Transfer and Intellectual Property (TT & IP) Workgroup for PAVM, he led the development of the TT & IP Enablement Unit. An influential vaccine advocate, Dr Nweneka is a renowned figure in international health who has contributed immensely to vaccine development in Africa through his relentless advocacy for local vaccine manufacturing, serving as a Board member of AVMI and the lead of the Advocacy Working Group for the last six years.